Liraglutide Subcutaneous Injection Suppliers & Bulk Manufacturers

Available Forms: Subcutaneous injection/Pre filled Pen

Available Strengths: 6 mg/mL solution

Reference Brands: Victoza(US & EU)

Category: Diabetes

Liraglutide is a GLP-1 receptor agonist that mimics incretin hormones, stimulating insulin secretion, suppressing glucagon release, and delaying gastric emptying. Benefits include improved glycemic control in type 2 diabetes and weight loss (obesity management). It also reduces cardiovascular risk in high-risk patients. Administered once daily for convenience. Liraglutide subcutaneous injection is available in Subcutaneous injection/Pre filled Pen and strengths such as 6 mg/mL solution. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Liraglutide subcutaneous injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Liraglutide subcutaneous injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Liraglutide injection, approved by both the FDA and EMA, is prescribed for type 2 diabetes, weight management, and cardiovascular risk reduction. Marketed under brand names like Victoza® and Saxenda®, it requires a prescription and proper medical supervision. In the U.S., it carries a boxed warning for thyroid C-cell tumors, while the EU mandates PSURs and risk management plans. Cold-chain storage and pharmacovigilance are required in both regions. For regulatory-compliant sourcing and global distribution of liraglutide injection, visit PharmaTradz.com.